Mobile

This clinical study investigates the effect of fidaxomicin in comparison to vancomycin in adult patients with an infection of Clostridium difficile, and are using medicinal products that suppress the ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-000531-88

This clinical study investigates the effect of fidaxomicin in comparison to vancomycin in adult patients with an infection of Clostridium difficile, and are using medicinal products that suppress the immune system

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to demonstrate superiority of fidaxomicin versus vancomycin for the sustained clinical cure of Clostridium difficile Infection (CDI) in adult patients receiving immunosuppressive therapy. Sustained clinical cure is defined as clinical cure without recurrence within 14 days from Test of Cure (TOC).

Critère d'inclusion

  • Adult patients with Clostridium difficile infection who are receiving immunosuppressive therapy

Liens